Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.635 USD | +0.27% | -1.58% | -44.52% |
14/05 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
09/05 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.52% | 462M | |
+35.71% | 50.93B | |
-0.35% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+12.16% | 26.02B | |
-22.56% | 18.9B | |
+7.43% | 13.21B | |
+24.69% | 12.17B | |
+29.38% | 12.16B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- RBC Lifts Price Target on Editas Medicine to $8 From $7, Maintains Sector Perform, Speculative Risk